Affiliate Oragnisation Session: Mobilise for action on STI! Developed by WHO, IAS, IUSTI
Tracks
Paediatrics Day
| Tuesday, September 17, 2024 |
| 11:00 AM - 12:30 PM |
| C2.1 |
Details
Chairs
Ismail Maatouk, World Health Organization Remco Peters, World Health Organization
In partnership with IAS and IUSTI, this pre-conference on sexually transmitted infections (STIs) aims to unite a diverse group of stakeholders—including civil society, community leaders, public health and clinical experts, programme managers, and policymakers—to catalyze action targeting the elimination of STIs as a public health concern by 2030. The meeting serves as a pivotal platform to emphasize the significance of STIs within the broader context of global health and the global HIV response, to cultivate new collaborations, and to mobilize advocacy efforts. Running alongside this major international scientific conference, the agenda will focus on expanding the global response through coordinated multisectoral networks, strengthening interactions between STI and HIV programmes, and acknowledging the interconnectedness of these health challenges. Through discussions and deliberations, participants and panelists will identify opportunities and key approaches to advance the WHO global STI targets by 2030. Building on the momentum from the first forum in Berlin, Germany, following the World Health Summit 2023, and from the AIDS 2024 pre-conference in Munich, Germany, this meeting will outline concrete next steps to increase political commitment, community engagement and innovation in global health.
Ismail Maatouk, World Health Organization Remco Peters, World Health Organization
In partnership with IAS and IUSTI, this pre-conference on sexually transmitted infections (STIs) aims to unite a diverse group of stakeholders—including civil society, community leaders, public health and clinical experts, programme managers, and policymakers—to catalyze action targeting the elimination of STIs as a public health concern by 2030. The meeting serves as a pivotal platform to emphasize the significance of STIs within the broader context of global health and the global HIV response, to cultivate new collaborations, and to mobilize advocacy efforts. Running alongside this major international scientific conference, the agenda will focus on expanding the global response through coordinated multisectoral networks, strengthening interactions between STI and HIV programmes, and acknowledging the interconnectedness of these health challenges. Through discussions and deliberations, participants and panelists will identify opportunities and key approaches to advance the WHO global STI targets by 2030. Building on the momentum from the first forum in Berlin, Germany, following the World Health Summit 2023, and from the AIDS 2024 pre-conference in Munich, Germany, this meeting will outline concrete next steps to increase political commitment, community engagement and innovation in global health.
Speaker
Dr Ismail MAATOUK
Physician
WHO HQ STIs
Why do STIs matter? - WHO perspective
11:00 AM - 11:20 AMBiography
Dr Janet Wilson
Consultant In Sexual Health & Hiv
Leeds Teaching Hospitals
Why do STIs matter?- IUSTI perspective
11:00 AM - 11:20 AMBiography
Dr Janet Wilson specialises in STIs at Leeds, UK. Her clinical and research interests are the application and cost-effectiveness of diagnostic tests for chlamydia and gonorrhoea, managing recurrent vaginal infections and infections in pregnancy. An IUSTI World Executive Committee Member since 2007, she is currently the IUSTI Past President.
Professor Andrew Grulich
Professor and Program Head HIV Epidemiology and Prevention Program
Kirby Institute
Why do STIs matter? - IAS perspective
Biography
Andrew is an internationally renowned authority in the transmission and prevention of HIV and sexually transmissible infections (STIs) and in the epidemiological relationship between immune deficiency, infection and cancer. He has worked in HIV research for more than thirty years, and at the Kirby Institute since 1995. His current research is mainly in two areas: first, the transmission and prevention of HIV and sexually transmitted infections in homosexual men, and second, the intersection between infection, altered immune function and cancer, particularly as it relates to HPV-related cancer and focusing on anal cancer.
Dr Remco Peters
Medical Officer
World Health Organization
Critical accelerator 1: accelerating innovation - Background and context
11:20 AM - 11:40 AMBiography
Dr Peters leads the STI care and treatment programme at the WHO since this year. He has almost 20 years’ experience working as clinician, epidemiologist, and researcher in the STI and HIV fields in low-resource settings across Southern Africa.
Scientia Professor Rebecca Guy
Program Head
The Kirby Institute
Critical accelerator 1: accelerating innovation - Diagnostics (Rapid POCT) in STIs
11:20 AM - 11:40 AMBiography
Rebecca Guy is a Professor in Epidemiology at the Kirby Institute, UNSW. She has expertise in the epidemiology of HIV, sexually transmissible infections and other infectious diseases, and evaluation of innovative interventions to maximise uptake of testing. She is lead investigator of the Australia Study of Health and Relationships.
Prof Kate Seib
Research Leader & Deputy Director
Institute for Glycomics, Griffith University
Critical accelerator 1: accelerating innovation -STI Vaccines
Biography
Professor Kate Seib's research includes the discovery and characterisation of gonococcal vaccine candidates, and mathematical modelling of the potential impact of gonococcal vaccines. She was involved in the development of the 4CMenB meningococcal vaccine and is currently leading two clinical trials to evaluate the ability of 4CMenB to prevent gonorrhoea.
Prof Nicola Low
Professor of Epidemiology And Public Health
University of Bern
Critical accelerator 2: increasing political commitment -Background and context
Biography
Nicola Low is an infectious disease epidemiologist with a background in genitourinary medicine and public health. Her main research interests are in the evaluation of screening interventions for the prevention of bacterial STIs, estimation of the burden of STIs and diagnostics for antimicrobial-resistant STIs
Dr Rachel Devi
Head Of Family Health Unit
Fiji Family Health Unit
Critical accelerator 2: increasing political commitment - Perspective from Fiji
11:40 AM - 12:00 PMBiography
Dr Rachel Devi, Head of Family Health Unit, Ministry of Health and Medical Services, Fiji. As a public health specialist in Fiji, I graduated from the Fiji School of Medicine in 2007 with an MBBS and, in 2017, from the University of Sydney with a master’s in international public health. I am currently pursing my PhD at the University of New South Wales. I have worked in various roles within the Ministry of Health for the past 17 years and in my current position for the past three years.
Dr Petronia Kaima
PNG National Health Department HIV program
Png National Health Department
Critical accelerator 2: increasing political commitment - Perspective from PNG
11:40 AM - 12:00 PMBiography
Dr. Petronia Kaima, Senior STI and HIV Medical Officer working with the National Department of Health, PNG
Mr Panusart Poonkasetwattana
Executive Director
APCOM Foundation
Critical accelerator 3: Strengthening community mobilization Background and context
12:00 PM - 12:20 PMBiography
Associate Professor Simon Graham
NHMRC fellow
University Of Melbourne
Critical accelerator 3: Strengthening community mobilization - Perspective from Indigenous populations
12:00 PM - 12:20 PMBiography
Simon is a NHMRC fellow at Sydney University. He has spent the last five years overseas with the last two years at the United Nations Population Fund’s Regional Office for Asia and the Pacific in Bangkok, Thailand.
Ms. Rena Janamnuaysook
Program Manager
Institute of HIV Research and Innovation
Critical accelerator 3: Strengthening community mobilization - Perspectives from key populations
12:00 PM - 12:20 PMBiography
Rena Janamnuaysook is a Program Manager for Implementation Science at the Institute of HIV Research and Innovation (IHRI) in Bangkok, Thailand, where she co-established Tangerine Clinic as the first transgender-led clinic in the region. She manages and provides technical guidance for the development and implementation of HIV research and programs for key populations in Thailand and in Asia.
Dr Remco Peters
Medical Officer
World Health Organization
Concluding remarks
12:20 PM - 12:30 PMBiography
Dr Peters leads the STI care and treatment programme at the WHO since this year. He has almost 20 years’ experience working as clinician, epidemiologist, and researcher in the STI and HIV fields in low-resource settings across Southern Africa.
Chair
Ismail MAATOUK
Physician
WHO HQ STIs
Remco Peters
Medical Officer
World Health Organization
